Valuation of one-off government subsidies during Covid-19
October 05, 2021
by a searcher from INSEAD in Hamburg, Deutschland
Dear search community,
I'm currently negotiating the company value for a business that received substantial government subsidies as Covid-relieve measure which boosted EBITDA.
I'm wondering whether this subsidy needs to be adjusted for in the EBITDA-baseline? You could argue that this is clearly non-operational. At the same time, the loss in revenue caused by the lockdowns was also an outside-effect. Any experience or thoughts on how to handle this?
Thanks a lot in advance,
Philipp
from University of Southern California in North Palm Beach, FL, USA
What’s the status of the employees? How has it changed and will it evolve? What about competitive advantages? The variation, composition and health of customers? What affects the landlord (which can affect the condition of premises and leases)? What about the sources of financing, before, during and after the most profound affect from the pandemic? Suppliers, such as the supply chain, pricing, terms of service, etc.?
How about the kinds of marketability of companies, and the buyers pursuing certain kinds of business, and the terms of their offers?
Keep in mind the business you buy today someday you will want to sell. What will that be like?
from University of Pennsylvania in Dubai - United Arab Emirates